CERO THERAPEUTICS HOLDINGS, INC. Depreciation
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Depreciation of $58.50 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. depreciation for the quarter ending 2026-06-30 was $58.50K, a 23.32% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. depreciation for the quarter ending 2025-09-30 was $69.35K, a 39.09% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. depreciation for the quarter ending 2025-06-30 was $76.29K, a 33.25% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. depreciation for the quarter ending 2025-03-31 was $76.29K.
| Period end | Depreciation | Depreciation 1 month | Depreciation 2 month | Depreciation 3 month | Depreciation 5 month | Depreciation 6 month | Depreciation 8 month | Depreciation 9 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $58.50K 10-Q · filed 2026-08-14 | $120.20K 10-Q · filed 2026-08-14 | ||||||
| 2025-09-30 | $69.35K 10-Q · filed 2025-11-19 | $145.65K derived: sum of 2 quarters · filed 2026-08-14 | $215.07K 10-Q · filed 2025-11-19 | |||||
| 2025-06-30 | $76.29K 10-Q · filed 2026-08-14 | $145.72K 10-Q · filed 2026-08-14 | ||||||
| 2025-03-31 | $76.29K 10-Q · filed 2026-05-15 | |||||||
| 2024-09-30 | $113.86K 10-Q · filed 2025-11-19 | $228.16K derived: sum of 2 quarters · filed 2025-11-19 | $304.45K 10-Q · filed 2025-11-19 | |||||
| 2024-06-30 | $114.30K 10-Q · filed 2025-08-22 | $190.59K 10-Q · filed 2025-08-22 | ||||||
| 2024-03-31 | $76.29K 10-Q · filed 2025-05-15 | |||||||
| 2024-02-14 | $76.29K 10-Q · filed 2024-05-17 | |||||||
| 2024-02-13 | $37.36K 10-Q · filed 2025-08-22 | |||||||
| 2023-09-30 | $115.39K 10-Q/A · filed 2024-11-20 | $230.78K derived: sum of 2 quarters · filed 2024-11-20 | $346.16K 10-Q/A · filed 2024-11-20 | |||||
| 2023-06-30 | $115.39K 10-Q · filed 2024-08-14 | $230.78K 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | $115.39K 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |